Aimei Health Technology Co., Ltd (AFJKU) stock analysis

Financial Services · Shell Companies

From the 10-K filed 2026-05-04

How it makes money

It earns interest income from holding IPO proceeds in a trust account while seeking a business combination.

As a blank check company, it has no ongoing operations or revenue-generating activities. Its financial results are limited to interest accrued on the cash and government securities held in its trust account, which are used to offset general administrative and compliance expenses.

What protects it: the moat

It claims its sponsorship and registration rights create a structured incentive to complete a business combination.

The company relies on its sponsor's capital commitment and registration rights to navigate the acquisition process. It maintains a trust account to hold capital securely for shareholders until a transaction is finalized.

What growth costs

It incurs ongoing legal and administrative costs to remain listed and complete its acquisition.

Expenditures consist primarily of compliance, auditing, and due diligence costs required to operate as a public entity and to finalize the merger with its identified target.

What could damage it

Failure to obtain regulatory approval for its target acquisition triggers liquidation, rendering its securities worthless.

If the required CSRC approval for the United Hydrogen merger is not obtained, the company must cease operations, wind up its affairs, and redeem public shares, which may result in a loss for investors compared to market trading prices.

About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Other companies in Shell Companies